Mohamad Hussein, James R. Berenson, Ruben Niesvizky, Nikhil Munshi, Jeffrey Matous, Ronald Sobecks, Kate Harrop, Jonathan G. Drachman, Nancy Whiting. A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma. haematol [Internet]. 2010May4 [cited 2024Nov.26];95(5):845-8. Available from: https://haematologica.org/article/view/5600